254 related articles for article (PubMed ID: 38673838)
41. [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].
Zhang B; Liu YX; Cao WF; Cao XC; Ning LS; Hao XS
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):471-6. PubMed ID: 19035119
[TBL] [Abstract][Full Text] [Related]
42. CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome.
Fan H; Yuan Y; Wang J; Zhou F; Zhang M; Giercksky KE; Nesland JM; Suo Z
Histopathology; 2013 Jun; 62(7):1028-37. PubMed ID: 23570416
[TBL] [Abstract][Full Text] [Related]
43. Identification of biomarker panels as predictors of severity in coronary artery disease.
Ben Braiek A; Chahed H; Dumont F; Abdelhak F; Hichem D; Gamra H; Baudin B
J Cell Mol Med; 2021 Feb; 25(3):1518-1530. PubMed ID: 33381894
[TBL] [Abstract][Full Text] [Related]
44. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
[TBL] [Abstract][Full Text] [Related]
45. Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus).
Lukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Siewko M; Szmitkowski M
J Clin Lab Anal; 2012 Feb; 26(2):73-81. PubMed ID: 22467322
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of preoperative serum concentrations of interleukin-6 as a prognostic marker in patients with esophageal cancer.
Maeda Y; Takeuchi H; Matsuda S; Okamura A; Fukuda K; Miyasho T; Nakamura R; Suda K; Wada N; Kawakubo H; Kitagawa Y
Esophagus; 2020 Jul; 17(3):279-288. PubMed ID: 31845119
[TBL] [Abstract][Full Text] [Related]
47. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
Murray GI; Duncan ME; O'Neil P; McKay JA; Melvin WT; Fothergill JE
J Pathol; 1998 Jul; 185(3):256-61. PubMed ID: 9771478
[TBL] [Abstract][Full Text] [Related]
48. Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer.
Singh RD; Haridas N; Patel JB; Shah FD; Shukla SN; Shah PM; Patel PS
Indian J Clin Biochem; 2010 Jul; 25(3):250-9. PubMed ID: 21731196
[TBL] [Abstract][Full Text] [Related]
49. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.
Shim KN; Jung SA; Joo YH; Yoo K
J Gastroenterol; 2007 Feb; 42(2):120-8. PubMed ID: 17351800
[TBL] [Abstract][Full Text] [Related]
50. A clinicopathological analysis of primary mucosal malignant melanoma.
Izumi D; Ishimoto T; Yoshida N; Nakamura K; Kosumi K; Tokunaga R; Sugihara H; Sawayama H; Karashima R; Imamura Y; Ida S; Hiyoshi Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Watanabe M; Baba H
Surg Today; 2015 Jul; 45(7):886-91. PubMed ID: 25297929
[TBL] [Abstract][Full Text] [Related]
51. Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas.
Cid S; Eiro N; González LO; Beridze N; Vazquez J; Vizoso FJ
Clin Breast Cancer; 2016 Aug; 16(4):e83-91. PubMed ID: 27266802
[TBL] [Abstract][Full Text] [Related]
52. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
Chiamulera MMA; Zancan CB; Remor AP; Cordeiro MF; Gleber-Netto FO; Baptistella AR
BMC Cancer; 2021 Feb; 21(1):205. PubMed ID: 33639868
[TBL] [Abstract][Full Text] [Related]
53. The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Szmitkowski M
Dis Markers; 2016; 2016():7963895. PubMed ID: 27041792
[TBL] [Abstract][Full Text] [Related]
54. IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis.
Inoue M; Takeuchi H; Matsuda S; Nishi T; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Kitagawa Y
Anticancer Res; 2021 Feb; 41(2):783-794. PubMed ID: 33517283
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers.
Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Clin Chem Lab Med; 2010 Oct; 48(10):1467-73. PubMed ID: 20604722
[TBL] [Abstract][Full Text] [Related]
57. Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid.
Zlatarova ZI; Softova EB; Dokova KG; Messmer EM
Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):425-31. PubMed ID: 21881840
[TBL] [Abstract][Full Text] [Related]
58. Matrix metalloproteinase-9 is a prognostic marker to predict survival of patients who underwent surgery due to rectal carcinoma.
Svagzdys S; Lesauskaite V; Pangonyte D; Saladzinskas Z; Tamelis A; Pavalkis D
Tohoku J Exp Med; 2011 Jan; 223(1):67-73. PubMed ID: 21212604
[TBL] [Abstract][Full Text] [Related]
59. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
[TBL] [Abstract][Full Text] [Related]
60. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
Chen H; Tian X; Luan Y; Lu H
Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
